ResearcherYanan University Affiliated HospitalActive in the last 2 years
Yufu Zhang
Matched on ORCID iD 0000-0003-0648-2058; OpenAlex author ID A5084697396.
Their work
- Papers
- 2 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Collaborators
- 4
2024: 1 paper · 2025: none · 2026: 1 paper
Papers 2
- Saikosaponin D overcomes gemcitabine resistance in pancreatic cancer via AKT/mTOR pathway inhibition and synergistic induction of apoptosis and autophagy. Last author DOI 10.3892/or.2025.9033↗
- Frontiers and future of immunotherapy for pancreatic cancer: from molecular mechanisms to clinical application. Co-author DOI 10.3389/fimmu.2024.1383978↗
Closest collaborators
The 4 strongest of 4 ranked by shared papers, trials and grants, with recent and small-team work weighing most.
- Rui Zheng · 2 shared papers, 2024–2026
- Paper Saikosaponin D overcomes gemcitabine resistance in pancreatic cancer via AKT/mTOR pathway inhibition and synergistic in… DOI 10.3892/or.2025.9033↗
- Paper Frontiers and future of immunotherapy for pancreatic cancer: from molecular mechanisms to clinical application. DOI 10.3389/fimmu.2024.1383978↗
- Yusi Liu · 2 shared papers, 2024–2026
- Paper Saikosaponin D overcomes gemcitabine resistance in pancreatic cancer via AKT/mTOR pathway inhibition and synergistic in… DOI 10.3892/or.2025.9033↗
- Paper Frontiers and future of immunotherapy for pancreatic cancer: from molecular mechanisms to clinical application. DOI 10.3389/fimmu.2024.1383978↗
- Xiaobin Liu · 1 shared paper, 2026
- Yuehong Guan · 1 shared paper, 2024
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.